aap Implantate AG (HAM:AAQ1) Debt-to-Equity : 0.18 (As of Jun. 2023)

View and export this data going back to 1999. Start your Free Trial

What is aap Implantate AG Debt-to-Equity?

aap Implantate AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €1.43 Mil. aap Implantate AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €1.14 Mil. aap Implantate AG's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €14.21 Mil. aap Implantate AG's debt to equity for the quarter that ended in Jun. 2023 was 0.18.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for aap Implantate AG's Debt-to-Equity or its related term are showing as below:

HAM:AAQ1' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.11 Max: 0.47
Current: 0.18

During the past 13 years, the highest Debt-to-Equity Ratio of aap Implantate AG was 0.47. The lowest was 0.00. And the median was 0.11.

HAM:AAQ1's Debt-to-Equity is ranked better than
54.3% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs HAM:AAQ1: 0.18

aap Implantate AG Debt-to-Equity Historical Data

The historical data trend for aap Implantate AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aap Implantate AG Debt-to-Equity Chart

aap Implantate AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.14

0.42

0.47

0.26

aap Implantate AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-Equity	Get a 7-Day Free Trial															0.42	0.47	0.24	0.26	0.18

Competitive Comparison of aap Implantate AG's Debt-to-Equity

For the Medical Devices subindustry, aap Implantate AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

aap Implantate AG's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's Debt-to-Equity falls into.

aap Implantate AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

aap Implantate AG's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.004	+	1.268)	/	12.827
	=	0.26

aap Implantate AG's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.425	+	1.137)	/	14.206
	=	0.18

aap Implantate AG (HAM:AAQ1) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

aap Implantate AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of aap Implantate AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

aap Implantate AG (HAM:AAQ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » aap Implantate AG (HAM:AAQ1) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

AAQ1:Germany

Address

Lorenzweg 5, Berlin, DEU, 12099

Website

https://www.aap.de

aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.

aap Implantate AG (HAM:AAQ1) Headlines

No Headlines